skip to main content
primary care & preventionformula

FRAX (Fracture Risk Assessment Tool)

iatroX editorial team · Updated · Record checked · editorial policy

FRAX estimates the 10-year probability of a major osteoporotic fracture (hip, spine, forearm, humerus) and hip fracture specifically, using clinical risk factors with or without femoral neck BMD. Country-specific models are available for >70 countries.

calculate with the official tool

Use the official calculator for this model, then return here for interpretation and related guidance.

Open the official FRAX calculator ↗
evidence

derivation

Developed by Kanis et al. (2008) at the University of Sheffield from meta-analyses of prospective population-based cohorts worldwide. Published in Osteoporos Int.

validation

Validated in >1 million patient-years of follow-up across multiple countries. FRAX integrates country-specific fracture and mortality rates, making it the most internationally applicable fracture risk tool.

guideline endorsements

NICE TA160/TA161: reference FRAX for fracture risk assessment. NOGG (National Osteoporosis Guideline Group, UK): uses FRAX with UK-specific intervention thresholds. IOF (International Osteoporosis Foundation) and NOF (US) reference FRAX. SIGN 142 (Osteoporosis) references FRAX.

regional interpretation
UK: Use FRAX with UK country model. NOGG provides age-specific intervention thresholds at nogg.org.uk.
US: NOF recommends treatment when FRAX 10-year hip fracture risk ≥3% or major osteoporotic fracture risk ≥20%.
EU: Country-specific models available. IOF provides guidance.
references
  1. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385-397.PMID: 18292978
  2. NOGG (National Osteoporosis Guideline Group). Clinical guideline for the prevention and treatment of osteoporosis. 2021.link ↗
  3. NICE Technology Appraisal TA464. Bisphosphonates for treating osteoporosis. 2017.link ↗